Luka Raguž
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Sphingolipid Metabolism and Signaling 7
- Lipid Membrane Structure and Behavior 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Synthetic Organic Chemistry Methods 4
- Carbohydrate Chemistry and Synthesis 3
- Co-authors
- Mathieu F. Chellat (2 shared papers)Rainer Riedl (3 shared papers)Christine Beemelmanns (11 shared papers)Huijuan Guo (3 shared papers)Marcel Kaiser (4 shared papers)Tobias Goris (1 shared paper)Gabriele Diekert (1 shared paper)Sandra Hoefgen (2 shared papers)
- Journals
- Angewandte Chemie International Edition (4 papers)ACS Chemical Biology (2 papers)European Journal of Medicinal Chemistry (1 paper)Chemical Society Reviews (1 paper)Chemical Science (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Luka Raguž
16 papers receiving 532 citations
Luka Raguž's Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Medicine 97
- Applied Microbiology and Biotechnology 26
- Microbiology 73
- Pharmacology 97
- Organic Chemistry 144
Countries citing papers authored by Luka Raguž
This map shows the geographic impact of Luka Raguž's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka Raguž with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka Raguž more than expected).
Fields of papers citing papers by Luka Raguž
This network shows the impact of papers produced by Luka Raguž. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka Raguž. The network helps show where Luka Raguž may publish in the future.
Co-authors
The 25 scholars most cited alongside Luka Raguž, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Antibiotic Resistance Hit paper breakdown → | 2016 | 387 |
| 2 | 2016 | 35 | |
| 3 | 2018 | 21 | |
| 4 | 2018 | 19 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 11 | |
| 7 | 2017 | 11 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2020 | 3 | |
| 14 | The need and value of routine screening of all pregnant women for hepatitis B surface antigen. | 1995 | 2 |
| 15 | 2024 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2019 | 0 |
About Luka Raguž
Luka Raguž is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Immunology and Infectious Diseases, having authored 17 papers that have together received 540 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Synthetic Organic Chemistry Methods (4 papers), Carbohydrate Chemistry and Synthesis (3 papers), Lipid Membrane Structure and Behavior (2 papers), Tuberculosis Research and Epidemiology (2 papers), Antibiotic Resistance in Bacteria (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Molecular Medicine (97 citations), Applied Microbiology and Biotechnology (26 citations), Microbiology (73 citations), Pharmacology (97 citations) and Organic Chemistry (144 citations). Luka Raguž has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Mathieu F. Chellat, Rainer Riedl, Christine Beemelmanns, Huijuan Guo, Marcel Kaiser, Tobias Goris, Gabriele Diekert, Sandra Hoefgen, Gerald Lackner and Helmar Görls. Their work appears in journals such as Angewandte Chemie International Edition, ACS Chemical Biology, European Journal of Medicinal Chemistry, Chemical Society Reviews and Chemical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.